ChromaCode

Diagnosing infectious diseases is based on a testing platform called PCR, which delivers accuracy and confidence to patients and doctors. While accurate, the approach requires advanced lab expertise and expensive equipment. With an experienced management team from Illumina, Google[x], and Luminex, ChromaCode’s instrument agnostic platform integrates reliable biochemical techniques with computational mathematics to enhance SARS-CoV-2, tick-borne pathogen, multi-drug resistance, and non-invasive prenatal testing.